NANOVECTORS FOR TARGETING AND DELOVERY OF THERAPEUTICS TO HER-2 NEU POSITIVE BREAST CANCER CELLS

$658,440FY2008Department of the ArmyDOD

The Methodist Hospital Research Institute, Houston TX

Investigators